Close
New

Medscape is available in 5 Language Editions – Choose your Edition here.

 

sodium hyaluronate (Rx)Brand and Other Names:Amvisc, Hyalgan, more...Amvisc Plus, Euflexxa, Healon, Healon GV, Healon5, AMO Vitrax, Nuflexxa, Supartz

 
 
 

Dosing & Uses

AdultPediatric

Dosage Forms & Strengths

intra-articular injection

  • 10mg/mL
  • 15mg/mL

cream topical

  • 0.2%

gel topical

  • 0.2%
  • 2.5%

transdermal gel injection

  • 20mg/mL

intraocular injection solution

  • 12mg/mL
  • 16mg/mL
  • 10mg/mL
more...

Osteoarthritis of Knee

Indicated for treatment of pain in osteoarthritis of the knee

Administer by intra-articular injection into the affected knee(s)

Euflexxa: Inject 20 mg (2 mL) qWeek for 3 weeks

Hyalgan: Inject 20 mg (2 mL) qWeek for 3-5 weeks

Supartz: Inject 25 mg (2.5 mL) qWeek for 5 weeks

Other information

  • Concomitant use of disinfectants containing quaternary ammonium salts (eg, benzalkonium chloride) for skin preparation can precipitate in presence of hyaluronic acid
  • Use strict aseptic injection technique
  • Inject the full contents of single syringe into 1 knee only; if treatment is bilateral, a separate syringe should be used for each knee

Ophthalmic Viscoelastic Devices (OVDs)

Surgical aid to protect corneal endothelium during anterior segment and vitreous procedures (eg, cataract extraction, intraocular lens implantation, corneal transplant, glaucoma filtration, retinal attachment surgery)

AMO Vitrax, Amvisc, Amvisc Plus, Healon, Healon GV, Healon5: Inject sufficient amount slowly (using cannula or needle) into anterior chamber or vitreous cavity of eye; some procedures/products require removal of the sodium hyaluronate following surgical completion

Skin Ulcers and Wounds

Cream: Apply a thin layer to wound or ulcer that have been cleaned and desinfected

Gel: Apply liberally once daily to ulcer cavity or wound and surrounding areas

Lip Augmentation

<21 years: Safety and efficacy not established

>21 years: 1.5 mL per lip (upper or lower) per treatment session

Safety & efficacy not established

Next

Adverse Effects

>10%

Intradermal Injection

  • Erythema (75-93%)
  • Swelling (91-03%)
  • Tenderness (61-92%)
  • Lumps/bumps (56-83$)
  • Discoloration (33-78%)
  • Pruritus (25-36%)

1-10%

Increased blood pressure (4%)

Fatigue (1%)

Pain at injection site (intra-articular) (3%)

Nausea (<2%)

Infection (1%)

Tendonitis (6%)

Limb pain (2%)

Parasthesia (1%)

Frequency Not Defined

Intra-articular injection

  • Arthralgia
  • Headache
  • Injection site pain
  • Anaphylactoid reaction

Intraocular administration

  • Increased IOP
  • Keratitis
  • Cystoid macular edema
  • Conjunctival hemorrhage
Previous
Next

Warnings

Contraindications

Intra-articular use

  • Hypersensitivity to hyaluronate preparations, avian-derived products (eg, eggs, feathers, poultry), gram-positive bacterial proteins
  • Do not inject in knees with infection or skin diseases in area of injection site or joint

Ophthalmic use

  • No known contraindications

Cautions

Intra-articular use

  • Transient increased inflammation in injected knee may occur
  • Avoid strenuous activity or prolonged (>1 hr) weight-bearing activities (eg, running, tennis) within 48 hr following injection
  • Pain relief may not be evident until after 3rd injection
  • Remove joint effusion, if present, before injection

Ophthalmic use

  • Use only if solution is clear
  • Monitor intraocular pressure
Previous
Next

Pregnancy & Lactation

Pregnancy Category: N/A

Lactation: Not known if excreted in breast milk; not recommended

Pregnancy Categories

A:Generally acceptable. Controlled studies in pregnant women show no evidence of fetal risk.

B:May be acceptable. Either animal studies show no risk but human studies not available or animal studies showed minor risks and human studies done and showed no risk.

C:Use with caution if benefits outweigh risks. Animal studies show risk and human studies not available or neither animal nor human studies done.

D:Use in LIFE-THREATENING emergencies when no safer drug available. Positive evidence of human fetal risk.

X:Do not use in pregnancy. Risks involved outweigh potential benefits. Safer alternatives exist.

NA:Information not available.

more...
Previous
Next

Pharmacology

Mechanism of Action

Sodium hyaluronate and its derivatives form a viscoelastic solution in water suitable for aqueous and vitreous humor in ophthalmic surgery; works as a lubricant, which plays an important role in managing interactions between adjacent tissues

Protects sking against friction and abrassion in the management of wounds and ulcers

Pharmacokinetics

Distribution: Slow (intravitreous injection)

Excretion: Canal of Schlemm (ophthalmic)

Previous
Next

Images

Previous
Next

Formulary

FormularyPatient Discounts

To view formulary information first create a list of plans. Your list will be saved and can be edited at any time.

Adding plans allows you to:

  • View the formulary and any restrictions for each plan.
  • Manage and view all your plans together – even plans in different states.
  • Compare formulary status to other drugs in the same class.
  • Access your plan list on any device – mobile or desktop.

The above information is provided for general informational and educational purposes only. Individual plans may vary and formulary information changes. Contact the applicable plan provider for the most current information.

Tier Description
1 This drug is available at the lowest co-pay. Most commonly, these are generic drugs.
2 This drug is available at a middle level co-pay. Most commonly, these are "preferred" (on formulary) brand drugs.
3 This drug is available at a higher level co-pay. Most commonly, these are "non-preferred" brand drugs.
4 This drug is available at a higher level co-pay. Most commonly, these are "non-preferred" brand drugs or specialty prescription products.
5 This drug is available at a higher level co-pay. Most commonly, these are "non-preferred" brand drugs or specialty prescription products.
6 This drug is available at a higher level co-pay. Most commonly, these are "non-preferred" brand drugs or specialty prescription products.
NC NOT COVERED – Drugs that are not covered by the plan.
Code Definition
PA Prior Authorization
Drugs that require prior authorization. This restriction requires that specific clinical criteria be met prior to the approval of the prescription.
QL Quantity Limits
Drugs that have quantity limits associated with each prescription. This restriction typically limits the quantity of the drug that will be covered.
ST Step Therapy
Drugs that have step therapy associated with each prescription. This restriction typically requires that certain criteria be met prior to approval for the prescription.
OR Other Restrictions
Drugs that have restrictions other than prior authorization, quantity limits, and step therapy associated with each prescription.
Add or Remove Plans
Plans for
Select State:
Non-Medicare PlansMedicare Plans

Select a box to add or remove a plan.

Select a class to view formulary status for similar drugs

Additional Offers
Email to Patient

From:

To:

The recipient will receive more details and instructions to access this offer.

By clicking send, you acknowledge that you have permission to email the recipient with this information.

Email Forms to Patient

From:

To:

The recipient will receive more details and instructions to access this offer.

By clicking send, you acknowledge that you have permission to email the recipient with this information.

Previous
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2016 by WebMD LLC. This website also contains material copyrighted by 3rd parties.